Cameron Pye

The biopharmaceutical sector continues to innovate peptide discovery innovations, from new macrocycles to new delivery methods and are thriving on strategic alliances, which allow for cross-functional sharing of knowledge, and experience to advance peptide drugs to patients faster. Hear first-hand how investors and key biotechs are keeping up with the peptide momentum through investments, alliances and collaborations.

Key questions to be addressed include:

• How to strategize the complexities, risks and decision-making strategies for choosing the right platform to invest and advance innovative approaches in the peptide industry?
• What are the key areas and spaces that peptides can fill in the biotechnology sector?
• What does it take for a small biotech to survive and get noticed from an investor or big pharma?